Abbott Laboratories ABT
NYSE ABT
$106.03 +0.51 (+0.48%)
As of: Sep 9, 2026 · 11:55 AM EDT

Abbott Laboratories (ABT) Operating Income (QoQ) (2009 - 2026)

Analysis

Abbott Laboratories (ABT) Operating Income (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 184.79 Bn 179.19 Bn 7.27 Bn
2 Intuitive Surgical 124.38 Bn 119.16 Bn 1.96 Bn
3 Medtronic 118.45 Bn 109.63 Bn 6.34 Bn
4 Stryker 105.32 Bn 101.84 Bn 4.50 Bn
5 Boston Scientific 66.71 Bn 66.17 Bn 3.85 Bn
6 Edwards Lifesciences 49.81 Bn 45.56 Bn 1.35 Bn
7 Alcon 34.03 Bn 32.58 Bn 1.68 Bn
8 Dexcom 32.35 Bn 30.40 Bn 830.00 Mn
9 Steris 21.17 Bn 20.68 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.27 Bn 17.86 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.87%
Mar 31, 2026 -40.25%
Dec 31, 2025 9.43%
Sep 30, 2025 0.24%
Jun 30, 2025 21.20%
Mar 31, 2025 -11.41%
Dec 31, 2024 2.80%
Sep 30, 2024 11.38%
Jun 30, 2024 20.42%
Mar 31, 2024 -22.13%
Dec 31, 2023 8.08%
Sep 30, 2023 6.81%
Jun 30, 2023 2.19%
Mar 31, 2023 15.72%
Dec 31, 2022 -26.33%
Sep 30, 2022 -25.51%
Jun 30, 2022 -18.41%
Mar 31, 2022 22.46%
Dec 31, 2021 -6.60%
Sep 30, 2021 82.90%